Archives
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-11
- 2018-10
- 2018-07
-
Fingolimod (FTY720): Redefining Immunomodulation for Transla
2026-06-26
This thought-leadership article explores the mechanistic and strategic dimensions of Fingolimod (FTY720) in translational science. Beyond its established role as an immunomodulatory agent for MS, we examine its emerging applications in in vivo immune cell engineering and neuroprotection. By integrating insights from recent nanomedicine research and referencing leading-edge resources, this article provides actionable guidance for researchers aiming to leverage Fingolimod’s unique properties in next-generation translational workflows.
-
Microfluidic Peptide/mRNA Complexes for Pulmonary Delivery
2026-06-26
This article analyzes the development of robust peptide/RNA complexes via microfluidic mixing for pulmonary delivery by nebulisation, as detailed in the reference study. The work demonstrates that cationic peptides can effectively deliver mRNA and siRNA to lung cells without loss of function after aerosolization, offering a promising alternative to lipid nanoparticles for respiratory RNA therapeutics.
-
Mecamylamine Hydrochloride Workflows in Neuropsychiatric Mod
2026-06-25
Mecamylamine hydrochloride empowers advanced dissection of nicotinic acetylcholine receptor signaling in both neuropsychiatric disorder and gut-brain axis research. This article details optimized experimental workflows, practical troubleshooting, and translational insights, highlighting how APExBIO’s trusted reagent accelerates discoveries in cholinergic circuitry.
-
Patient-Derived 3D Spheroid Models Advance Prostate Cancer R
2026-06-25
The referenced study establishes patient-derived, three-dimensional spheroid cultures from organ-confined prostate cancer tissues as robust translational models. These spheroids better capture tumor heterogeneity and microenvironment for in vitro drug testing, providing new avenues for mechanistic and therapeutic investigation.
-
Tricine-SDS-PAGE Electrophoresis System Gel Preparation Kit
2026-06-24
The Tricine-SDS-PAGE Electrophoresis System Gel Preparation Kit enables high-resolution separation of proteins and peptides in the 1–10 kDa range, addressing a major limitation of standard Tris-glycine SDS-PAGE for small molecule resolution. It is intended strictly for research workflows and is not suitable for diagnostic or clinical applications.
-
Optimizing Plant Protein Studies with Protease Inhibitor Coc
2026-06-23
This article addresses key laboratory challenges in plant protein analysis, focusing on reproducibility, sensitivity, and workflow compatibility. Drawing from real-world scenarios, we demonstrate how the Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO) (SKU K1011) from APExBIO safeguards protein integrity in plant extracts, streamlining workflows for Western blotting and kinase assays. Evidence-based insights and protocol guidance empower researchers to achieve robust, reproducible results.
-
Thiamet G: Applied O-GlcNAcase Inhibitor Workflows in Resear
2026-06-23
Thiamet G empowers researchers to precisely modulate O-GlcNAcylation, unlocking robust models for neurodegeneration, bone formation, and leukemia sensitization. With unparalleled selectivity and solubility, this O-GlcNAcase inhibitor from APExBIO streamlines experimental design and reproducibility across cell and animal systems.
-
Maraviroc (UK-427857): Optimizing CCR5 Antagonist Workflows
2026-06-22
Maraviroc (UK-427857) empowers researchers to dissect CCR5-mediated HIV-1 entry and neuroinflammatory pathways with unmatched precision. This article demystifies experimental setup, advanced assay design, and troubleshooting—anchored by translational insights and robust, data-driven protocol guidance.
-
USP36-Snail1 Axis: Ribosome Biogenesis and Tumor Survival Un
2026-06-22
This article analyzes how USP36 stabilizes nucleolar Snail1 to promote ribosome biogenesis and solid tumor cell survival during ribotoxic stress. The findings clarify resistance mechanisms to ribosome-targeting therapies and suggest new strategies for overcoming solid tumor resilience.
-
Nilotinib (AMN-107) in Translational Oncology and Neurobiolo
2026-06-21
Explore how Nilotinib (AMN-107) advances chronic myeloid leukemia research and kinase signaling studies, while critically examining its translational relevance in neurodegeneration. This article uniquely bridges robust kinase inhibitor workflows with insights from the latest cellular neurobiology findings.
-
Anti-Fibrotic Effects of 1-Phenyl-2-Pentanol in Hepatic Stel
2026-06-20
This study investigates 1-phenyl-2-pentanol (1-PHE), a bioactive compound from Moringa oleifera, for its capacity to attenuate liver fibrosis by targeting hepatic stellate cell activation. Through transcriptomic and proteomic profiling, the research identifies inhibition of TGF-β1 and Wnt/β-catenin signaling as core mechanisms, offering new avenues for anti-fibrotic agent development.
-
Cefepime (BMY-28142): Advanced Applications in CNS Infection
2026-06-19
Cefepime (BMY-28142) empowers researchers to model central nervous system infections and multidrug resistance with unmatched precision, thanks to its broad-spectrum activity and blood-brain barrier penetration. This article unpacks stepwise protocols, troubleshooting guidance, and actionable insights—translating recent breakthroughs into robust, reproducible bench workflows.
-
ARCA Cy5 EGFP mRNA (5-moUTP): Precision in mRNA Delivery Ass
2026-06-19
ARCA Cy5 EGFP mRNA (5-moUTP) provides an unparalleled platform for quantitative, fluorescence-based mRNA delivery and localization studies in mammalian cells. By integrating 5-methoxyuridine modification and Cy5 labeling, this APExBIO reagent offers superior translational efficiency and immune evasion, enabling robust benchmarking and optimization of delivery systems.
-
EZ Cap Cy5 Firefly Luciferase mRNA: Precision Dual Reporter
2026-06-18
Discover how EZ Cap Cy5 Firefly Luciferase mRNA enables unprecedented precision in gene expression studies and intracellular mRNA tracking. This in-depth analysis reveals technical advances in 5-moUTP modified mRNA for immune evasion, robust translation, and dual-mode imaging.
-
EZ Cap™ Human PTEN mRNA (ψUTP): Workflow, Innovations & Tips
2026-06-18
EZ Cap™ Human PTEN mRNA (ψUTP) delivers robust, immune-evasive PTEN expression for advanced cancer research, enabling precise PI3K/Akt pathway inhibition and resistance reversal. This guide translates recent nanoparticle-mediated delivery breakthroughs and hands-on optimization into actionable protocols for translational and preclinical workflows.